Xencor | XNCR - Ordinary Share Capital

Stock Price
11.22
Daily Change
-0.66 -5.56%
Monthly
-9.88%
Yearly
39.21%
Q2 Forecast
10.99

Xencor reported $74.06M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
Amgen USD 540M 1000K Mar/2026
Arrowhead Research USD 137.39M 1.69M Dec/2025
AstraZeneca USD 1.55B 73K Mar/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Xencor USD 74.06M 2.19M Mar/2026